| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 69 | 2020 | 824 | 14.560 |
Why?
|
| Endoscopy, Gastrointestinal | 69 | 2020 | 888 | 14.230 |
Why?
|
| Gastroscopy | 37 | 2024 | 213 | 10.890 |
Why?
|
| Obesity, Morbid | 49 | 2024 | 1298 | 8.930 |
Why?
|
| Suture Techniques | 38 | 2020 | 775 | 8.650 |
Why?
|
| Stomach | 33 | 2020 | 701 | 7.600 |
Why?
|
| Bariatric Surgery | 39 | 2024 | 1001 | 7.420 |
Why?
|
| Gastroplasty | 16 | 2022 | 159 | 6.720 |
Why?
|
| Gastric Fistula | 15 | 2020 | 73 | 6.420 |
Why?
|
| Endoscopy, Digestive System | 22 | 2019 | 358 | 5.350 |
Why?
|
| Endoscopy | 29 | 2022 | 1854 | 4.510 |
Why?
|
| Jejunum | 15 | 2019 | 475 | 4.400 |
Why?
|
| Gastric Balloon | 12 | 2020 | 36 | 4.180 |
Why?
|
| Natural Orifice Endoscopic Surgery | 12 | 2020 | 119 | 3.830 |
Why?
|
| Gastrostomy | 10 | 2019 | 325 | 3.750 |
Why?
|
| Obesity | 44 | 2022 | 13090 | 3.320 |
Why?
|
| Weight Loss | 35 | 2024 | 2721 | 3.130 |
Why?
|
| Weight Gain | 22 | 2020 | 2359 | 2.980 |
Why?
|
| Postoperative Complications | 44 | 2021 | 15832 | 2.790 |
Why?
|
| Endosonography | 21 | 2020 | 626 | 2.770 |
Why?
|
| Anastomotic Leak | 7 | 2019 | 170 | 2.470 |
Why?
|
| Laparoscopy | 15 | 2020 | 2041 | 2.310 |
Why?
|
| Surgical Instruments | 8 | 2019 | 381 | 1.940 |
Why?
|
| Intestinal Perforation | 5 | 2019 | 254 | 1.920 |
Why?
|
| Stents | 13 | 2020 | 3195 | 1.890 |
Why?
|
| Bariatrics | 4 | 2020 | 36 | 1.870 |
Why?
|
| Gastrectomy | 8 | 2020 | 693 | 1.860 |
Why?
|
| Reoperation | 24 | 2020 | 4329 | 1.840 |
Why?
|
| Abdominal Pain | 9 | 2017 | 1070 | 1.840 |
Why?
|
| Colonoscopy | 9 | 2019 | 1409 | 1.820 |
Why?
|
| Gastric Mucosa | 8 | 2019 | 602 | 1.790 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 9 | 2019 | 520 | 1.780 |
Why?
|
| Bariatric Medicine | 3 | 2019 | 12 | 1.780 |
Why?
|
| Anastomosis, Roux-en-Y | 11 | 2019 | 86 | 1.760 |
Why?
|
| Drainage | 10 | 2020 | 1183 | 1.690 |
Why?
|
| Cutaneous Fistula | 3 | 2018 | 79 | 1.690 |
Why?
|
| Sutures | 5 | 2016 | 282 | 1.640 |
Why?
|
| Gastric Outlet Obstruction | 4 | 2019 | 55 | 1.620 |
Why?
|
| Duodenum | 9 | 2020 | 495 | 1.620 |
Why?
|
| Anastomosis, Surgical | 9 | 2019 | 991 | 1.510 |
Why?
|
| Swine | 37 | 2019 | 5995 | 1.490 |
Why?
|
| Equipment Design | 30 | 2019 | 3522 | 1.480 |
Why?
|
| Gastric Stump | 4 | 2018 | 8 | 1.470 |
Why?
|
| Magnetics | 4 | 2019 | 597 | 1.450 |
Why?
|
| Gastroenterology | 6 | 2019 | 593 | 1.420 |
Why?
|
| Peptic Ulcer | 4 | 2017 | 214 | 1.390 |
Why?
|
| Pancreatitis, Acute Necrotizing | 5 | 2020 | 174 | 1.390 |
Why?
|
| Heart Valve Prosthesis Implantation | 31 | 2016 | 1566 | 1.380 |
Why?
|
| Feasibility Studies | 28 | 2024 | 5315 | 1.380 |
Why?
|
| Intestinal Obstruction | 4 | 2017 | 433 | 1.370 |
Why?
|
| Pancreatitis | 6 | 2019 | 1087 | 1.340 |
Why?
|
| Dilatation, Pathologic | 6 | 2019 | 527 | 1.330 |
Why?
|
| Colon | 11 | 2015 | 1801 | 1.320 |
Why?
|
| Treatment Outcome | 93 | 2024 | 65371 | 1.290 |
Why?
|
| Dilatation | 3 | 2019 | 311 | 1.240 |
Why?
|
| Gastrointestinal Diseases | 8 | 2020 | 1206 | 1.230 |
Why?
|
| Esophageal Achalasia | 3 | 2020 | 98 | 1.220 |
Why?
|
| Aortic Valve Stenosis | 20 | 2022 | 2032 | 1.200 |
Why?
|
| Inappropriate ADH Syndrome | 4 | 2020 | 59 | 1.180 |
Why?
|
| Stomach Diseases | 3 | 2020 | 134 | 1.150 |
Why?
|
| Humans | 283 | 2024 | 768166 | 1.130 |
Why?
|
| Pylorus | 2 | 2019 | 86 | 1.130 |
Why?
|
| Argon Plasma Coagulation | 4 | 2020 | 26 | 1.110 |
Why?
|
| Portasystemic Shunt, Surgical | 2 | 2016 | 40 | 1.080 |
Why?
|
| Device Removal | 7 | 2019 | 643 | 1.040 |
Why?
|
| Endoscopes, Gastrointestinal | 4 | 2018 | 45 | 1.030 |
Why?
|
| Clinical Competence | 13 | 2019 | 4858 | 1.020 |
Why?
|
| Esophageal Stenosis | 2 | 2017 | 196 | 1.000 |
Why?
|
| Duodenal Diseases | 2 | 2015 | 101 | 0.980 |
Why?
|
| Pancreatectomy | 4 | 2015 | 825 | 0.970 |
Why?
|
| Middle Aged | 120 | 2024 | 223492 | 0.930 |
Why?
|
| Gastric Emptying | 3 | 2024 | 247 | 0.920 |
Why?
|
| Debridement | 4 | 2020 | 494 | 0.920 |
Why?
|
| Pyloric Antrum | 1 | 2024 | 66 | 0.910 |
Why?
|
| Gastroscopes | 3 | 2014 | 20 | 0.890 |
Why?
|
| Intussusception | 2 | 2017 | 116 | 0.890 |
Why?
|
| Dissection | 3 | 2014 | 299 | 0.870 |
Why?
|
| Gastroenterostomy | 3 | 2019 | 18 | 0.870 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2019 | 12252 | 0.870 |
Why?
|
| Water Deprivation | 3 | 2020 | 19 | 0.860 |
Why?
|
| Sclerotherapy | 2 | 2016 | 183 | 0.860 |
Why?
|
| Female | 163 | 2024 | 397192 | 0.850 |
Why?
|
| Endoscopes | 3 | 2009 | 169 | 0.830 |
Why?
|
| Male | 146 | 2024 | 364719 | 0.820 |
Why?
|
| Ultrasonography, Interventional | 7 | 2020 | 1523 | 0.820 |
Why?
|
| Pancreatic Diseases | 4 | 2017 | 354 | 0.800 |
Why?
|
| Aortic Valve | 19 | 2015 | 1970 | 0.780 |
Why?
|
| Gastroparesis | 1 | 2024 | 143 | 0.780 |
Why?
|
| Ghrelin | 3 | 2020 | 251 | 0.760 |
Why?
|
| Intestinal Fistula | 2 | 2019 | 146 | 0.750 |
Why?
|
| Septal Occluder Device | 2 | 2019 | 126 | 0.730 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2020 | 374 | 0.730 |
Why?
|
| Adult | 89 | 2024 | 223646 | 0.720 |
Why?
|
| Pancreatic Cyst | 3 | 2019 | 372 | 0.720 |
Why?
|
| Gallbladder | 2 | 2019 | 308 | 0.710 |
Why?
|
| Conscious Sedation | 2 | 2016 | 534 | 0.710 |
Why?
|
| Hyponatremia | 5 | 2021 | 279 | 0.710 |
Why?
|
| Pancreatic Pseudocyst | 2 | 2020 | 112 | 0.700 |
Why?
|
| Sus scrofa | 8 | 2019 | 430 | 0.670 |
Why?
|
| Fluid Therapy | 2 | 2020 | 587 | 0.670 |
Why?
|
| Colonoscopes | 2 | 2010 | 17 | 0.660 |
Why?
|
| Blood Glucose | 8 | 2019 | 6430 | 0.660 |
Why?
|
| Gastroesophageal Reflux | 3 | 2020 | 836 | 0.660 |
Why?
|
| Hepatic Veins | 2 | 2016 | 112 | 0.650 |
Why?
|
| Organizational Policy | 2 | 2019 | 435 | 0.650 |
Why?
|
| Lactulose | 1 | 2019 | 32 | 0.650 |
Why?
|
| Retrospective Studies | 50 | 2022 | 81762 | 0.640 |
Why?
|
| Educational Measurement | 3 | 2017 | 1260 | 0.640 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2019 | 50 | 0.640 |
Why?
|
| Models, Animal | 11 | 2017 | 2120 | 0.630 |
Why?
|
| Abdomen, Acute | 1 | 2019 | 122 | 0.630 |
Why?
|
| Intestinal Mucosa | 6 | 2019 | 3044 | 0.630 |
Why?
|
| Ablation Techniques | 2 | 2019 | 255 | 0.630 |
Why?
|
| Foreign Bodies | 2 | 2015 | 403 | 0.630 |
Why?
|
| Heart Valve Prosthesis | 21 | 2016 | 1468 | 0.620 |
Why?
|
| Societies | 1 | 2019 | 107 | 0.610 |
Why?
|
| Bronchial Fistula | 1 | 2018 | 83 | 0.610 |
Why?
|
| Dictyostelium | 1 | 2018 | 70 | 0.610 |
Why?
|
| Cholangitis | 1 | 2019 | 110 | 0.600 |
Why?
|
| Gastrointestinal Transit | 1 | 2019 | 101 | 0.600 |
Why?
|
| Surgical Staplers | 2 | 2008 | 34 | 0.600 |
Why?
|
| Common Bile Duct | 2 | 2015 | 106 | 0.600 |
Why?
|
| Bile Reflux | 1 | 2017 | 11 | 0.580 |
Why?
|
| Cholagogues and Choleretics | 1 | 2017 | 39 | 0.580 |
Why?
|
| Prostheses and Implants | 5 | 2011 | 1276 | 0.580 |
Why?
|
| Breath Tests | 1 | 2019 | 300 | 0.580 |
Why?
|
| Coronavirus | 1 | 2020 | 156 | 0.580 |
Why?
|
| Cholestasis | 3 | 2015 | 385 | 0.580 |
Why?
|
| Portal Vein | 3 | 2017 | 435 | 0.570 |
Why?
|
| Necrosis | 2 | 2019 | 1616 | 0.570 |
Why?
|
| Forensic Psychiatry | 1 | 2019 | 198 | 0.570 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2017 | 81 | 0.570 |
Why?
|
| Esophageal Perforation | 2 | 2017 | 65 | 0.570 |
Why?
|
| Gastritis | 2 | 2017 | 199 | 0.570 |
Why?
|
| Surgical Stapling | 3 | 2019 | 98 | 0.560 |
Why?
|
| Intestinal Diseases | 2 | 2019 | 505 | 0.560 |
Why?
|
| Choledocholithiasis | 1 | 2017 | 50 | 0.560 |
Why?
|
| Hypopituitarism | 4 | 2016 | 253 | 0.560 |
Why?
|
| Pilot Projects | 17 | 2024 | 8741 | 0.560 |
Why?
|
| Bezoars | 1 | 2017 | 29 | 0.560 |
Why?
|
| Constriction, Pathologic | 5 | 2019 | 1104 | 0.560 |
Why?
|
| Capsules | 2 | 2016 | 193 | 0.560 |
Why?
|
| Societies, Medical | 4 | 2018 | 3968 | 0.550 |
Why?
|
| Equipment Failure | 2 | 2019 | 585 | 0.550 |
Why?
|
| Sigmoid Diseases | 1 | 2017 | 60 | 0.550 |
Why?
|
| Electrosurgery | 1 | 2017 | 53 | 0.550 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2017 | 109 | 0.550 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2016 | 26 | 0.540 |
Why?
|
| Colon, Sigmoid | 1 | 2017 | 124 | 0.540 |
Why?
|
| Laser Coagulation | 1 | 2019 | 334 | 0.540 |
Why?
|
| Fellowships and Scholarships | 5 | 2019 | 1135 | 0.540 |
Why?
|
| Deglutition Disorders | 2 | 2019 | 640 | 0.530 |
Why?
|
| Jejunoileal Bypass | 1 | 2016 | 13 | 0.530 |
Why?
|
| Needles | 3 | 2020 | 461 | 0.520 |
Why?
|
| Postcholecystectomy Syndrome | 1 | 2015 | 3 | 0.520 |
Why?
|
| Peritoneal Cavity | 3 | 2019 | 135 | 0.520 |
Why?
|
| Mitomycin | 1 | 2017 | 261 | 0.520 |
Why?
|
| Gloves, Protective | 1 | 2015 | 23 | 0.520 |
Why?
|
| Coronary Stenosis | 1 | 2022 | 802 | 0.520 |
Why?
|
| Choledochostomy | 1 | 2015 | 16 | 0.520 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 385 | 0.520 |
Why?
|
| Drug-Eluting Stents | 1 | 2022 | 681 | 0.510 |
Why?
|
| Follow-Up Studies | 34 | 2021 | 39348 | 0.510 |
Why?
|
| Midazolam | 2 | 2015 | 267 | 0.510 |
Why?
|
| Diet Therapy | 1 | 2016 | 150 | 0.510 |
Why?
|
| Intestinal Polyps | 1 | 2015 | 105 | 0.500 |
Why?
|
| Body Mass Index | 14 | 2020 | 13053 | 0.490 |
Why?
|
| Ulcer | 1 | 2016 | 203 | 0.490 |
Why?
|
| Policy Making | 1 | 2019 | 546 | 0.480 |
Why?
|
| Trichotillomania | 1 | 2017 | 178 | 0.480 |
Why?
|
| Gastrointestinal Tract | 3 | 2019 | 840 | 0.480 |
Why?
|
| Recurrence | 11 | 2020 | 8509 | 0.480 |
Why?
|
| Deep Sedation | 1 | 2016 | 119 | 0.480 |
Why?
|
| Traction | 2 | 2019 | 112 | 0.480 |
Why?
|
| Colorectal Neoplasms | 4 | 2019 | 6974 | 0.480 |
Why?
|
| Omentum | 1 | 2015 | 168 | 0.470 |
Why?
|
| Hernia, Ventral | 2 | 2009 | 220 | 0.470 |
Why?
|
| Education, Medical, Graduate | 3 | 2018 | 2420 | 0.460 |
Why?
|
| Education, Distance | 1 | 2018 | 260 | 0.460 |
Why?
|
| Hormones | 1 | 2018 | 866 | 0.450 |
Why?
|
| Digestive System Fistula | 2 | 2014 | 8 | 0.450 |
Why?
|
| Coronavirus Infections | 6 | 2020 | 3115 | 0.450 |
Why?
|
| Diabetes Insipidus | 3 | 2021 | 144 | 0.450 |
Why?
|
| Fentanyl | 2 | 2015 | 451 | 0.450 |
Why?
|
| Pneumonia, Viral | 6 | 2020 | 3238 | 0.450 |
Why?
|
| Abdominal Abscess | 1 | 2015 | 153 | 0.450 |
Why?
|
| Computer Simulation | 5 | 2017 | 6283 | 0.450 |
Why?
|
| Prosthesis Implantation | 4 | 2019 | 594 | 0.440 |
Why?
|
| Prosthesis-Related Infections | 2 | 2019 | 497 | 0.440 |
Why?
|
| Esophagogastric Junction | 1 | 2016 | 351 | 0.440 |
Why?
|
| Helicobacter pylori | 1 | 2017 | 380 | 0.430 |
Why?
|
| Ileum | 1 | 2016 | 558 | 0.430 |
Why?
|
| Hair | 1 | 2017 | 508 | 0.430 |
Why?
|
| Helicobacter Infections | 1 | 2017 | 390 | 0.430 |
Why?
|
| Video Recording | 5 | 2020 | 976 | 0.420 |
Why?
|
| Colonic Polyps | 1 | 2018 | 557 | 0.420 |
Why?
|
| Placebos | 1 | 2017 | 1667 | 0.420 |
Why?
|
| Osteoprotegerin | 5 | 2015 | 179 | 0.420 |
Why?
|
| Sodium Morrhuate | 1 | 2012 | 6 | 0.420 |
Why?
|
| Aged | 72 | 2021 | 171504 | 0.410 |
Why?
|
| Self-Injurious Behavior | 1 | 2019 | 568 | 0.400 |
Why?
|
| Prospective Studies | 32 | 2023 | 54926 | 0.400 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2020 | 1126 | 0.400 |
Why?
|
| Pancreas | 1 | 2019 | 1700 | 0.400 |
Why?
|
| Portal Pressure | 3 | 2017 | 62 | 0.400 |
Why?
|
| Sclerosing Solutions | 1 | 2012 | 79 | 0.400 |
Why?
|
| Foreign-Body Migration | 4 | 2012 | 220 | 0.400 |
Why?
|
| Intraoperative Complications | 2 | 2016 | 1171 | 0.400 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2014 | 219 | 0.400 |
Why?
|
| Stomach Ulcer | 1 | 2012 | 118 | 0.400 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2012 | 247 | 0.380 |
Why?
|
| Manikins | 1 | 2013 | 254 | 0.380 |
Why?
|
| Acute Disease | 8 | 2019 | 7243 | 0.380 |
Why?
|
| Animals | 47 | 2019 | 169246 | 0.380 |
Why?
|
| Cefazolin | 1 | 2012 | 95 | 0.380 |
Why?
|
| Echocardiography, Transesophageal | 14 | 2016 | 1096 | 0.380 |
Why?
|
| Jejunal Diseases | 1 | 2011 | 45 | 0.380 |
Why?
|
| Prediabetic State | 1 | 2017 | 548 | 0.370 |
Why?
|
| Time Factors | 28 | 2020 | 40218 | 0.370 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2017 | 843 | 0.370 |
Why?
|
| Proton Pump Inhibitors | 1 | 2016 | 552 | 0.370 |
Why?
|
| Cell Division | 1 | 2018 | 4473 | 0.370 |
Why?
|
| Anesthetics, Intravenous | 1 | 2014 | 397 | 0.360 |
Why?
|
| Pancreaticojejunostomy | 1 | 2010 | 26 | 0.360 |
Why?
|
| Computer Systems | 1 | 2012 | 469 | 0.360 |
Why?
|
| Alanine Transaminase | 3 | 2019 | 606 | 0.360 |
Why?
|
| Cell Cycle | 1 | 2018 | 2932 | 0.350 |
Why?
|
| Duodenal Obstruction | 1 | 2010 | 23 | 0.340 |
Why?
|
| Celiac Plexus | 1 | 2010 | 34 | 0.340 |
Why?
|
| Brain Injuries | 4 | 2020 | 2057 | 0.340 |
Why?
|
| Curriculum | 4 | 2019 | 3782 | 0.340 |
Why?
|
| Exercise Therapy | 1 | 2016 | 939 | 0.330 |
Why?
|
| British Columbia | 9 | 2015 | 240 | 0.330 |
Why?
|
| Dumping Syndrome | 1 | 2009 | 22 | 0.330 |
Why?
|
| Aged, 80 and over | 46 | 2020 | 59629 | 0.330 |
Why?
|
| Abdomen | 3 | 2019 | 1136 | 0.330 |
Why?
|
| Acute Coronary Syndrome | 1 | 2022 | 2194 | 0.320 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2846 | 0.320 |
Why?
|
| Mitral Valve Insufficiency | 8 | 2016 | 1415 | 0.320 |
Why?
|
| Immunocompetence | 1 | 2009 | 138 | 0.320 |
Why?
|
| Fluoroscopy | 5 | 2020 | 947 | 0.320 |
Why?
|
| Poloxamer | 1 | 2009 | 56 | 0.320 |
Why?
|
| Neuroendocrine Tumors | 1 | 2015 | 659 | 0.310 |
Why?
|
| Surgical Stomas | 4 | 2017 | 45 | 0.310 |
Why?
|
| Gastrointestinal Hormones | 2 | 2020 | 101 | 0.310 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2009 | 141 | 0.310 |
Why?
|
| Pancreatic Ducts | 1 | 2010 | 330 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2019 | 20760 | 0.310 |
Why?
|
| Colitis | 1 | 2017 | 1242 | 0.310 |
Why?
|
| Esophageal Diseases | 2 | 2006 | 167 | 0.310 |
Why?
|
| Task Performance and Analysis | 4 | 2018 | 771 | 0.310 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 1481 | 0.310 |
Why?
|
| Surface-Active Agents | 1 | 2009 | 151 | 0.300 |
Why?
|
| Models, Anatomic | 4 | 2016 | 680 | 0.300 |
Why?
|
| Chronic Disease | 9 | 2020 | 9384 | 0.300 |
Why?
|
| Surgical Mesh | 2 | 2009 | 315 | 0.300 |
Why?
|
| Laser Therapy | 1 | 2015 | 1107 | 0.300 |
Why?
|
| Pandemics | 7 | 2021 | 8748 | 0.300 |
Why?
|
| Common Bile Duct Diseases | 1 | 2007 | 36 | 0.290 |
Why?
|
| Critical Pathways | 1 | 2011 | 476 | 0.290 |
Why?
|
| Surgery, Computer-Assisted | 5 | 2017 | 1003 | 0.290 |
Why?
|
| Suicide | 1 | 2019 | 1606 | 0.290 |
Why?
|
| Duodenoscopes | 1 | 2007 | 43 | 0.280 |
Why?
|
| Fundoplication | 1 | 2008 | 145 | 0.280 |
Why?
|
| Anal Canal | 2 | 2019 | 376 | 0.280 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2012 | 583 | 0.280 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2016 | 619 | 0.280 |
Why?
|
| Hypnotics and Sedatives | 1 | 2015 | 1191 | 0.270 |
Why?
|
| Pressure | 4 | 2016 | 1172 | 0.270 |
Why?
|
| Coronary Artery Bypass | 2 | 2007 | 2191 | 0.270 |
Why?
|
| Ovariectomy | 2 | 2006 | 613 | 0.270 |
Why?
|
| Motor Skills | 3 | 2014 | 523 | 0.270 |
Why?
|
| Cholecystectomy | 1 | 2009 | 408 | 0.270 |
Why?
|
| Colonic Neoplasms | 2 | 2017 | 2541 | 0.270 |
Why?
|
| Digestive System Diseases | 1 | 2008 | 152 | 0.270 |
Why?
|
| Aortic Valve Insufficiency | 6 | 2015 | 577 | 0.270 |
Why?
|
| Adolescent Psychiatry | 1 | 2008 | 165 | 0.270 |
Why?
|
| Mucocele | 1 | 2006 | 51 | 0.260 |
Why?
|
| Esophageal Fistula | 1 | 2006 | 60 | 0.260 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2006 | 142 | 0.260 |
Why?
|
| Single-Payer System | 1 | 2006 | 35 | 0.260 |
Why?
|
| Sterilization, Tubal | 1 | 2006 | 78 | 0.250 |
Why?
|
| Esophageal and Gastric Varices | 2 | 2020 | 215 | 0.250 |
Why?
|
| Duodenoscopy | 2 | 2019 | 45 | 0.250 |
Why?
|
| Mouth | 3 | 2015 | 383 | 0.250 |
Why?
|
| Child Psychiatry | 1 | 2008 | 230 | 0.250 |
Why?
|
| Congresses as Topic | 3 | 2008 | 812 | 0.250 |
Why?
|
| Prosthesis Failure | 7 | 2017 | 1208 | 0.250 |
Why?
|
| Heart Valve Diseases | 6 | 2012 | 1030 | 0.240 |
Why?
|
| Disease Models, Animal | 11 | 2019 | 18349 | 0.240 |
Why?
|
| Biosensing Techniques | 1 | 2011 | 662 | 0.240 |
Why?
|
| Reproducibility of Results | 16 | 2017 | 20227 | 0.240 |
Why?
|
| Diagnosis, Differential | 7 | 2018 | 13014 | 0.240 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2235 | 0.230 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2006 | 236 | 0.230 |
Why?
|
| Diuresis | 1 | 2004 | 107 | 0.230 |
Why?
|
| Nerve Block | 2 | 2017 | 716 | 0.230 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2022 | 1135 | 0.230 |
Why?
|
| Granulation Tissue | 2 | 2016 | 92 | 0.220 |
Why?
|
| Wound Healing | 2 | 2017 | 2809 | 0.220 |
Why?
|
| Heart Transplantation | 2 | 2017 | 3301 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 3 | 2017 | 5446 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 4 | 2019 | 7477 | 0.220 |
Why?
|
| Sensitivity and Specificity | 12 | 2018 | 14729 | 0.220 |
Why?
|
| Hysterectomy | 2 | 2006 | 863 | 0.220 |
Why?
|
| Pituitary Diseases | 1 | 2004 | 137 | 0.220 |
Why?
|
| Patient Selection | 11 | 2020 | 4260 | 0.210 |
Why?
|
| Iontophoresis | 1 | 2023 | 74 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 4058 | 0.210 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2016 | 1899 | 0.210 |
Why?
|
| Vasopressins | 1 | 2004 | 358 | 0.210 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2009 | 617 | 0.210 |
Why?
|
| Polymers | 1 | 2010 | 1630 | 0.200 |
Why?
|
| Education, Medical, Continuing | 3 | 2018 | 829 | 0.200 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2006 | 881 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 5 | 2020 | 7454 | 0.200 |
Why?
|
| Adenoma | 3 | 2019 | 2159 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 10399 | 0.200 |
Why?
|
| Otitis Media with Effusion | 1 | 2023 | 115 | 0.190 |
Why?
|
| Severity of Illness Index | 15 | 2021 | 15948 | 0.190 |
Why?
|
| Risk Factors | 22 | 2020 | 74944 | 0.190 |
Why?
|
| Waiting Lists | 1 | 2006 | 779 | 0.180 |
Why?
|
| Prosthesis Design | 13 | 2016 | 2125 | 0.180 |
Why?
|
| Equipment Safety | 4 | 2014 | 250 | 0.180 |
Why?
|
| Young Adult | 17 | 2021 | 60066 | 0.180 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11669 | 0.180 |
Why?
|
| Rectal Neoplasms | 2 | 2020 | 1183 | 0.180 |
Why?
|
| Antidiuretic Agents | 1 | 2020 | 21 | 0.180 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2020 | 20 | 0.180 |
Why?
|
| Gonadotropins | 2 | 2016 | 241 | 0.180 |
Why?
|
| Prevalence | 8 | 2020 | 15869 | 0.180 |
Why?
|
| Sphenoid Sinus | 1 | 2021 | 101 | 0.180 |
Why?
|
| Esophagoscopy | 2 | 2017 | 398 | 0.180 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2020 | 87 | 0.170 |
Why?
|
| Bacitracin | 1 | 2019 | 24 | 0.170 |
Why?
|
| Survival Rate | 10 | 2013 | 12840 | 0.170 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2019 | 23 | 0.170 |
Why?
|
| Hypernatremia | 1 | 2020 | 78 | 0.170 |
Why?
|
| Evidence-Based Medicine | 4 | 2017 | 3706 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2011 | 3390 | 0.170 |
Why?
|
| Peptide YY | 1 | 2020 | 135 | 0.170 |
Why?
|
| Neuroendoscopy | 1 | 2021 | 100 | 0.170 |
Why?
|
| Pancreatic Juice | 1 | 2019 | 60 | 0.170 |
Why?
|
| Cadaver | 3 | 2016 | 1363 | 0.160 |
Why?
|
| Therapeutic Irrigation | 2 | 2019 | 297 | 0.160 |
Why?
|
| Plastics | 1 | 2020 | 119 | 0.160 |
Why?
|
| Esophagitis, Peptic | 1 | 2020 | 77 | 0.160 |
Why?
|
| Infusions, Parenteral | 1 | 2019 | 396 | 0.160 |
Why?
|
| United States | 15 | 2020 | 73039 | 0.160 |
Why?
|
| Rectum | 3 | 2020 | 900 | 0.160 |
Why?
|
| Heart Septal Defects | 1 | 2020 | 191 | 0.160 |
Why?
|
| Liver Cirrhosis | 2 | 2020 | 1960 | 0.160 |
Why?
|
| Splanchnic Circulation | 1 | 2019 | 122 | 0.160 |
Why?
|
| Body Fluids | 1 | 2020 | 321 | 0.160 |
Why?
|
| Catheterization | 7 | 2009 | 1430 | 0.160 |
Why?
|
| Digestive System Neoplasms | 1 | 2019 | 82 | 0.160 |
Why?
|
| Spores, Fungal | 1 | 2018 | 90 | 0.150 |
Why?
|
| Pancreatic Fistula | 1 | 2019 | 149 | 0.150 |
Why?
|
| Brazil | 2 | 2020 | 1250 | 0.150 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2021 | 180 | 0.150 |
Why?
|
| Hospitals, University | 1 | 2020 | 570 | 0.150 |
Why?
|
| Ampulla of Vater | 2 | 2010 | 150 | 0.150 |
Why?
|
| Basal Metabolism | 1 | 2019 | 163 | 0.150 |
Why?
|
| Endocarditis, Bacterial | 1 | 2002 | 436 | 0.150 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2006 | 1024 | 0.150 |
Why?
|
| Positron-Emission Tomography | 3 | 2017 | 6669 | 0.150 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2020 | 156 | 0.150 |
Why?
|
| Wireless Technology | 2 | 2015 | 102 | 0.150 |
Why?
|
| Blind Loop Syndrome | 1 | 2017 | 4 | 0.150 |
Why?
|
| Tensile Strength | 4 | 2018 | 332 | 0.150 |
Why?
|
| Wound Closure Techniques | 1 | 2019 | 88 | 0.150 |
Why?
|
| Hemostasis, Surgical | 1 | 2018 | 128 | 0.150 |
Why?
|
| Mitral Valve | 3 | 2016 | 1475 | 0.150 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2004 | 1724 | 0.150 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2002 | 530 | 0.140 |
Why?
|
| Retreatment | 3 | 2020 | 598 | 0.140 |
Why?
|
| Ascites | 1 | 2019 | 338 | 0.140 |
Why?
|
| Sampling Studies | 1 | 2019 | 615 | 0.140 |
Why?
|
| Hernia | 1 | 2017 | 67 | 0.140 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.140 |
Why?
|
| Bioprosthesis | 6 | 2012 | 593 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2019 | 414 | 0.140 |
Why?
|
| Cohort Studies | 14 | 2020 | 41754 | 0.140 |
Why?
|
| Suction | 2 | 2017 | 268 | 0.140 |
Why?
|
| Risk Assessment | 12 | 2019 | 24315 | 0.140 |
Why?
|
| Metals | 2 | 2020 | 713 | 0.140 |
Why?
|
| Temporal Bone | 2 | 2012 | 683 | 0.140 |
Why?
|
| Gigantism | 1 | 2016 | 15 | 0.140 |
Why?
|
| Pituitary Neoplasms | 2 | 2016 | 1322 | 0.140 |
Why?
|
| Manometry | 1 | 2019 | 459 | 0.140 |
Why?
|
| Time | 1 | 2018 | 552 | 0.130 |
Why?
|
| Injections | 2 | 2010 | 840 | 0.130 |
Why?
|
| Treatment Failure | 3 | 2012 | 2661 | 0.130 |
Why?
|
| Review Literature as Topic | 2 | 2017 | 297 | 0.130 |
Why?
|
| Zenker Diverticulum | 1 | 2016 | 28 | 0.130 |
Why?
|
| Cholecystitis, Acute | 1 | 2016 | 81 | 0.130 |
Why?
|
| Postprandial Period | 1 | 2018 | 320 | 0.130 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2016 | 144 | 0.130 |
Why?
|
| Fluorometry | 1 | 2015 | 99 | 0.130 |
Why?
|
| Capsule Endoscopy | 2 | 2014 | 106 | 0.130 |
Why?
|
| Facial Pain | 1 | 2016 | 121 | 0.130 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2017 | 219 | 0.130 |
Why?
|
| Combined Modality Therapy | 3 | 2017 | 8542 | 0.120 |
Why?
|
| Regional Health Planning | 1 | 2015 | 95 | 0.120 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 12077 | 0.120 |
Why?
|
| Cause of Death | 2 | 2012 | 3721 | 0.120 |
Why?
|
| Endocrinology | 1 | 2021 | 443 | 0.120 |
Why?
|
| Insulin, Long-Acting | 1 | 2015 | 59 | 0.120 |
Why?
|
| Incidence | 6 | 2019 | 21538 | 0.120 |
Why?
|
| Hydrocortisone | 3 | 2016 | 1841 | 0.120 |
Why?
|
| Accreditation | 1 | 2018 | 476 | 0.120 |
Why?
|
| Norfloxacin | 1 | 2015 | 24 | 0.120 |
Why?
|
| Hypoglycemic Agents | 3 | 2017 | 3109 | 0.120 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 419 | 0.120 |
Why?
|
| Esophagitis | 1 | 2016 | 164 | 0.120 |
Why?
|
| Colonic Diseases | 1 | 2017 | 204 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 7 | 2014 | 6526 | 0.120 |
Why?
|
| Fluorescein | 2 | 2015 | 176 | 0.120 |
Why?
|
| Learning Curve | 1 | 2017 | 232 | 0.120 |
Why?
|
| Public Opinion | 1 | 2019 | 486 | 0.120 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2014 | 28 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2009 | 845 | 0.120 |
Why?
|
| Administration, Topical | 1 | 2017 | 703 | 0.120 |
Why?
|
| Diet, Reducing | 1 | 2018 | 487 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
| Thyroid Nodule | 1 | 2022 | 767 | 0.120 |
Why?
|
| Catheter Ablation | 1 | 2008 | 2780 | 0.120 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2015 | 353 | 0.120 |
Why?
|
| Feeding Behavior | 2 | 2017 | 3205 | 0.120 |
Why?
|
| Interviews as Topic | 2 | 2014 | 2741 | 0.120 |
Why?
|
| Biopsy | 2 | 2017 | 6793 | 0.120 |
Why?
|
| Length of Stay | 6 | 2019 | 6498 | 0.120 |
Why?
|
| Deglutition | 1 | 2015 | 208 | 0.110 |
Why?
|
| Adolescent | 16 | 2021 | 89169 | 0.110 |
Why?
|
| Education, Dental | 1 | 2016 | 220 | 0.110 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2017 | 388 | 0.110 |
Why?
|
| Predictive Value of Tests | 10 | 2016 | 15454 | 0.110 |
Why?
|
| Hypertriglyceridemia | 1 | 2017 | 293 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2019 | 1826 | 0.110 |
Why?
|
| Logistic Models | 7 | 2014 | 13290 | 0.110 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 21206 | 0.110 |
Why?
|
| Heart Injuries | 1 | 2015 | 207 | 0.110 |
Why?
|
| Lidocaine | 2 | 2023 | 546 | 0.110 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2016 | 227 | 0.110 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2016 | 615 | 0.110 |
Why?
|
| Genes, APC | 1 | 2014 | 145 | 0.110 |
Why?
|
| Acromegaly | 1 | 2016 | 317 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 22291 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 985 | 0.110 |
Why?
|
| Echocardiography, Stress | 1 | 2014 | 138 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 5536 | 0.110 |
Why?
|
| Paraganglioma | 1 | 2014 | 143 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2020 | 1741 | 0.110 |
Why?
|
| Cholelithiasis | 1 | 2014 | 408 | 0.110 |
Why?
|
| Waist Circumference | 1 | 2017 | 935 | 0.100 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 14783 | 0.100 |
Why?
|
| Chi-Square Distribution | 4 | 2013 | 3436 | 0.100 |
Why?
|
| Radiology, Interventional | 1 | 2017 | 483 | 0.100 |
Why?
|
| Gastric Lavage | 1 | 2012 | 17 | 0.100 |
Why?
|
| Pheochromocytoma | 1 | 2014 | 328 | 0.100 |
Why?
|
| Comorbidity | 5 | 2017 | 10590 | 0.100 |
Why?
|
| Parenteral Nutrition | 1 | 2017 | 663 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2019 | 1480 | 0.100 |
Why?
|
| Blood Transfusion | 2 | 2020 | 1309 | 0.100 |
Why?
|
| Program Evaluation | 2 | 2018 | 2507 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2014 | 251 | 0.100 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2014 | 191 | 0.100 |
Why?
|
| Sex Factors | 3 | 2019 | 10632 | 0.100 |
Why?
|
| Melena | 1 | 2011 | 32 | 0.100 |
Why?
|
| Myocardial Infarction | 4 | 2013 | 11519 | 0.100 |
Why?
|
| Glucocorticoids | 2 | 2015 | 2167 | 0.100 |
Why?
|
| Remission Induction | 1 | 2017 | 2410 | 0.100 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 646 | 0.100 |
Why?
|
| Digestive System | 1 | 2012 | 244 | 0.100 |
Why?
|
| Fasting | 1 | 2018 | 1610 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2017 | 8543 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 4423 | 0.090 |
Why?
|
| Insulin Resistance | 2 | 2018 | 3986 | 0.090 |
Why?
|
| Ear Neoplasms | 1 | 2012 | 118 | 0.090 |
Why?
|
| Pelvic Floor | 1 | 2012 | 138 | 0.090 |
Why?
|
| Genetic Heterogeneity | 1 | 2014 | 736 | 0.090 |
Why?
|
| International Classification of Diseases | 1 | 2017 | 937 | 0.090 |
Why?
|
| Triglycerides | 2 | 2017 | 2464 | 0.090 |
Why?
|
| Abdominal Wall | 1 | 2012 | 166 | 0.090 |
Why?
|
| Skull Neoplasms | 1 | 2012 | 173 | 0.090 |
Why?
|
| Linear Models | 3 | 2012 | 5884 | 0.090 |
Why?
|
| Tricuspid Valve | 1 | 2014 | 419 | 0.090 |
Why?
|
| Ischemia | 1 | 2019 | 1900 | 0.090 |
Why?
|
| Survival Analysis | 4 | 2012 | 10101 | 0.090 |
Why?
|
| Emergencies | 1 | 2017 | 1221 | 0.090 |
Why?
|
| Ventricular Function, Right | 1 | 2015 | 629 | 0.090 |
Why?
|
| Vacuum | 2 | 2020 | 65 | 0.090 |
Why?
|
| Models, Educational | 1 | 2013 | 375 | 0.090 |
Why?
|
| Nitriles | 1 | 2015 | 980 | 0.090 |
Why?
|
| Workload | 1 | 2016 | 849 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2010 | 5953 | 0.090 |
Why?
|
| Canada | 6 | 2015 | 2130 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 1402 | 0.090 |
Why?
|
| Ultrasonography | 7 | 2016 | 6004 | 0.090 |
Why?
|
| Colectomy | 1 | 2015 | 696 | 0.090 |
Why?
|
| Hypotension | 2 | 2014 | 888 | 0.090 |
Why?
|
| Palliative Care | 2 | 2019 | 3643 | 0.090 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2014 | 362 | 0.080 |
Why?
|
| Metabolomics | 1 | 2019 | 1674 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 948 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 1377 | 0.080 |
Why?
|
| Parotid Neoplasms | 1 | 2011 | 158 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2015 | 3683 | 0.080 |
Why?
|
| Neodymium | 1 | 2009 | 20 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2018 | 2575 | 0.080 |
Why?
|
| Electrocoagulation | 1 | 2010 | 156 | 0.080 |
Why?
|
| Leadership | 1 | 2019 | 1397 | 0.080 |
Why?
|
| Methylcellulose | 1 | 2009 | 34 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2014 | 735 | 0.080 |
Why?
|
| Adiposity | 1 | 2019 | 1895 | 0.080 |
Why?
|
| Skull Base | 1 | 2012 | 294 | 0.080 |
Why?
|
| Eating | 1 | 2015 | 1542 | 0.080 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2010 | 187 | 0.080 |
Why?
|
| Myocardial Contraction | 1 | 2014 | 1525 | 0.080 |
Why?
|
| Triage | 1 | 2015 | 997 | 0.080 |
Why?
|
| Pancreas Transplantation | 1 | 2009 | 193 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 2360 | 0.080 |
Why?
|
| Hospital Costs | 1 | 2014 | 957 | 0.080 |
Why?
|
| Nausea | 1 | 2011 | 682 | 0.080 |
Why?
|
| Electromagnetic Fields | 1 | 2010 | 289 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 1397 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2006 | 5520 | 0.080 |
Why?
|
| Lymphedema | 1 | 2015 | 527 | 0.080 |
Why?
|
| Hospital Mortality | 3 | 2015 | 5349 | 0.080 |
Why?
|
| Solutions | 1 | 2009 | 409 | 0.070 |
Why?
|
| Beds | 1 | 2008 | 48 | 0.070 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2017 | 26 | 0.070 |
Why?
|
| Chest Pain | 2 | 2005 | 1101 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 951 | 0.070 |
Why?
|
| Gels | 1 | 2009 | 423 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2009 | 526 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 2202 | 0.070 |
Why?
|
| Endocarditis | 2 | 2012 | 352 | 0.070 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 1281 | 0.070 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2010 | 515 | 0.070 |
Why?
|
| Echocardiography, Doppler | 2 | 2012 | 898 | 0.070 |
Why?
|
| Thrombosis | 2 | 2019 | 2957 | 0.070 |
Why?
|
| Liver | 3 | 2018 | 7577 | 0.070 |
Why?
|
| Population Surveillance | 2 | 2014 | 2596 | 0.070 |
Why?
|
| General Surgery | 1 | 2008 | 1720 | 0.070 |
Why?
|
| Adiponectin | 1 | 2012 | 1117 | 0.070 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2008 | 216 | 0.070 |
Why?
|
| Hormone Replacement Therapy | 2 | 2016 | 757 | 0.070 |
Why?
|
| Image Enhancement | 2 | 2008 | 2880 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2892 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 11095 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 1946 | 0.060 |
Why?
|
| Quality Improvement | 2 | 2018 | 3857 | 0.060 |
Why?
|
| Capsid Proteins | 1 | 2009 | 468 | 0.060 |
Why?
|
| Age Factors | 3 | 2019 | 18412 | 0.060 |
Why?
|
| Internet | 1 | 2018 | 3110 | 0.060 |
Why?
|
| Body Composition | 1 | 2015 | 2462 | 0.060 |
Why?
|
| Technology, Radiologic | 1 | 2006 | 160 | 0.060 |
Why?
|
| Hemodynamics | 5 | 2015 | 4194 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 1885 | 0.060 |
Why?
|
| Prognosis | 8 | 2019 | 30010 | 0.060 |
Why?
|
| Hernia, Hiatal | 1 | 2006 | 91 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2011 | 997 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2013 | 2278 | 0.060 |
Why?
|
| Alberta | 1 | 2004 | 67 | 0.060 |
Why?
|
| Antigens, Viral | 1 | 2009 | 995 | 0.060 |
Why?
|
| Crystallization | 1 | 2006 | 520 | 0.060 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 684 | 0.060 |
Why?
|
| Proportional Hazards Models | 4 | 2014 | 12543 | 0.060 |
Why?
|
| Body Weight | 1 | 2015 | 4627 | 0.060 |
Why?
|
| Microscopy | 1 | 2010 | 909 | 0.060 |
Why?
|
| Diarrhea | 2 | 2017 | 1320 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3780 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2014 | 2145 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2008 | 659 | 0.060 |
Why?
|
| Gamma Rays | 1 | 2006 | 319 | 0.060 |
Why?
|
| Critical Care | 1 | 2017 | 2715 | 0.060 |
Why?
|
| Emotions | 1 | 2016 | 2767 | 0.060 |
Why?
|
| Heart Ventricles | 2 | 2015 | 3841 | 0.060 |
Why?
|
| Thirst | 1 | 2004 | 42 | 0.060 |
Why?
|
| Quality of Health Care | 2 | 2011 | 4310 | 0.060 |
Why?
|
| Arginine Vasopressin | 1 | 2004 | 125 | 0.060 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 3858 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2010 | 2357 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 1528 | 0.060 |
Why?
|
| Optics and Photonics | 1 | 2006 | 307 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2014 | 2258 | 0.060 |
Why?
|
| Genetic Testing | 2 | 2014 | 3591 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 1622 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10760 | 0.060 |
Why?
|
| Lighting | 1 | 2006 | 210 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 18065 | 0.060 |
Why?
|
| Lipids | 1 | 2015 | 3343 | 0.050 |
Why?
|
| Registries | 5 | 2020 | 8375 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 957 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 657 | 0.050 |
Why?
|
| Insulin | 1 | 2018 | 6607 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2004 | 326 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 1930 | 0.050 |
Why?
|
| Echocardiography | 6 | 2013 | 5047 | 0.050 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2007 | 372 | 0.050 |
Why?
|
| Sensory Thresholds | 1 | 2004 | 377 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2010 | 1005 | 0.050 |
Why?
|
| Aortic Aneurysm | 1 | 2008 | 649 | 0.050 |
Why?
|
| Urine | 1 | 2004 | 362 | 0.050 |
Why?
|
| Rats | 1 | 2019 | 23760 | 0.050 |
Why?
|
| Aneurysm | 1 | 2006 | 343 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2016 | 12465 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2015 | 4214 | 0.050 |
Why?
|
| Esophagectomy | 1 | 2006 | 481 | 0.050 |
Why?
|
| Diagnostic Imaging | 2 | 2014 | 3533 | 0.050 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 2076 | 0.050 |
Why?
|
| Middle Ear Ventilation | 1 | 2023 | 101 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2017 | 3463 | 0.050 |
Why?
|
| Office Visits | 1 | 2006 | 595 | 0.050 |
Why?
|
| Vagina | 1 | 2007 | 850 | 0.050 |
Why?
|
| Boston | 1 | 2014 | 9374 | 0.050 |
Why?
|
| Random Allocation | 3 | 2011 | 2396 | 0.050 |
Why?
|
| Tympanic Membrane | 1 | 2023 | 232 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2014 | 3800 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 3941 | 0.050 |
Why?
|
| Thyrotropin | 1 | 2004 | 834 | 0.050 |
Why?
|
| Inflammation | 2 | 2011 | 10873 | 0.050 |
Why?
|
| Hypotonic Solutions | 1 | 2020 | 48 | 0.040 |
Why?
|
| Sodium | 1 | 2006 | 1597 | 0.040 |
Why?
|
| Radiometry | 1 | 2006 | 818 | 0.040 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2020 | 56 | 0.040 |
Why?
|
| Cyanoacrylates | 1 | 2020 | 47 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3251 | 0.040 |
Why?
|
| Proteins | 1 | 2015 | 6009 | 0.040 |
Why?
|
| Thoracic Surgery | 1 | 2006 | 727 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2013 | 4063 | 0.040 |
Why?
|
| Expert Testimony | 1 | 2021 | 266 | 0.040 |
Why?
|
| Syndrome | 1 | 2006 | 3272 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2010 | 3583 | 0.040 |
Why?
|
| Survivors | 2 | 2009 | 2381 | 0.040 |
Why?
|
| Quality of Life | 2 | 2011 | 13490 | 0.040 |
Why?
|
| Peripheral Arterial Disease | 1 | 2010 | 1304 | 0.040 |
Why?
|
| Cognition | 1 | 2016 | 7073 | 0.040 |
Why?
|
| Age Distribution | 1 | 2004 | 2873 | 0.040 |
Why?
|
| Dehydration | 1 | 2020 | 216 | 0.040 |
Why?
|
| Data Collection | 1 | 2008 | 3327 | 0.040 |
Why?
|
| Ethanol | 1 | 2005 | 1331 | 0.040 |
Why?
|
| Hospitalization | 2 | 2021 | 10840 | 0.040 |
Why?
|
| Europe | 2 | 2016 | 3436 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2013 | 1643 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 36743 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 1398 | 0.040 |
Why?
|
| Contrast Media | 1 | 2011 | 5330 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 9419 | 0.040 |
Why?
|
| Hydrocephalus | 1 | 2004 | 768 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 4712 | 0.040 |
Why?
|
| Shock | 1 | 2020 | 316 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2016 | 1232 | 0.040 |
Why?
|
| Mass Screening | 2 | 2016 | 5458 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2018 | 417 | 0.040 |
Why?
|
| Alcoholism | 1 | 2008 | 1980 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2004 | 1835 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 4568 | 0.030 |
Why?
|
| Education, Dental, Graduate | 1 | 2016 | 48 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 2496 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 1281 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 8616 | 0.030 |
Why?
|
| Ireland | 1 | 2016 | 170 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4598 | 0.030 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2017 | 166 | 0.030 |
Why?
|
| Emergency Medicine | 1 | 2005 | 1223 | 0.030 |
Why?
|
| ROC Curve | 2 | 2015 | 3628 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2009 | 4492 | 0.030 |
Why?
|
| Transducers, Pressure | 1 | 2015 | 51 | 0.030 |
Why?
|
| Motion | 2 | 2010 | 790 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 2008 | 0.030 |
Why?
|
| Disease-Free Survival | 3 | 2014 | 6847 | 0.030 |
Why?
|
| Patient Discharge | 2 | 2005 | 3479 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 371 | 0.030 |
Why?
|
| Optical Phenomena | 1 | 2015 | 104 | 0.030 |
Why?
|
| Electric Power Supplies | 1 | 2015 | 96 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2021 | 1573 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 15662 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2015 | 161 | 0.030 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 157 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3447 | 0.030 |
Why?
|
| Materials Testing | 1 | 2018 | 872 | 0.030 |
Why?
|
| Phlebography | 1 | 2015 | 326 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 627 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2015 | 315 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 4262 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 3929 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 520 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 714 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2016 | 6340 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 2599 | 0.030 |
Why?
|
| Algorithms | 4 | 2019 | 14164 | 0.030 |
Why?
|
| Sepsis | 1 | 2007 | 2608 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 505 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1906 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2004 | 4541 | 0.030 |
Why?
|
| Thyroxine | 1 | 2016 | 665 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2012 | 75 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2015 | 592 | 0.030 |
Why?
|
| Safety | 2 | 2009 | 1159 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 548 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 863 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 1743 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2018 | 1217 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 6568 | 0.020 |
Why?
|
| Recovery of Function | 2 | 2014 | 2981 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2017 | 886 | 0.020 |
Why?
|
| Consensus | 1 | 2021 | 3212 | 0.020 |
Why?
|
| Ohio | 1 | 2012 | 321 | 0.020 |
Why?
|
| Patient Care Team | 2 | 2015 | 2523 | 0.020 |
Why?
|
| Jejunostomy | 1 | 2011 | 61 | 0.020 |
Why?
|
| Mastoid | 1 | 2011 | 100 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2015 | 797 | 0.020 |
Why?
|
| Denmark | 1 | 2013 | 776 | 0.020 |
Why?
|
| Phospholipids | 1 | 2015 | 787 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 537 | 0.020 |
Why?
|
| Injections, Jet | 1 | 2010 | 8 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2013 | 9669 | 0.020 |
Why?
|
| Otologic Surgical Procedures | 1 | 2012 | 148 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2021 | 2783 | 0.020 |
Why?
|
| Observer Variation | 1 | 2016 | 2622 | 0.020 |
Why?
|
| Heterozygote | 1 | 2016 | 2798 | 0.020 |
Why?
|
| Research | 1 | 2008 | 1979 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3623 | 0.020 |
Why?
|
| Disease Management | 1 | 2020 | 2536 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 30238 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 1183 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 2107 | 0.020 |
Why?
|
| Facial Nerve | 1 | 2011 | 277 | 0.020 |
Why?
|
| Kidney | 1 | 2004 | 7064 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 1493 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 2512 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2003 | 5107 | 0.020 |
Why?
|
| Child | 4 | 2023 | 80917 | 0.020 |
Why?
|
| Autopsy | 1 | 2012 | 1011 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 4620 | 0.020 |
Why?
|
| Health Services Research | 1 | 2015 | 1815 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2008 | 6874 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2015 | 826 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 1375 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1388 | 0.020 |
Why?
|
| International Cooperation | 1 | 2014 | 1436 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2015 | 1091 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6395 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2017 | 9015 | 0.020 |
Why?
|
| Metformin | 1 | 2015 | 909 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2010 | 541 | 0.020 |
Why?
|
| Mycophenolic Acid | 1 | 2009 | 348 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2009 | 777 | 0.020 |
Why?
|
| Electromagnetic Phenomena | 1 | 2007 | 159 | 0.020 |
Why?
|
| Health Personnel | 1 | 2020 | 3385 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2862 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6316 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2011 | 981 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2011 | 1791 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 1805 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2009 | 750 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 1027 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6894 | 0.020 |
Why?
|
| Antidiarrheals | 1 | 2005 | 46 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2744 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2017 | 2257 | 0.020 |
Why?
|
| Horses | 1 | 2006 | 295 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3814 | 0.020 |
Why?
|
| Aortography | 1 | 2006 | 422 | 0.010 |
Why?
|
| Mortality | 1 | 2016 | 2911 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 2709 | 0.010 |
Why?
|
| Microbubbles | 1 | 2006 | 137 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 26379 | 0.010 |
Why?
|
| Otolaryngology | 1 | 2012 | 699 | 0.010 |
Why?
|
| Amyloidosis | 1 | 2012 | 878 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2004 | 7951 | 0.010 |
Why?
|
| Risk | 1 | 2016 | 9613 | 0.010 |
Why?
|
| Specialization | 1 | 2009 | 779 | 0.010 |
Why?
|
| Medicaid | 1 | 2017 | 2840 | 0.010 |
Why?
|
| Telemedicine | 1 | 2021 | 3109 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2015 | 3124 | 0.010 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2004 | 164 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2784 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 7852 | 0.010 |
Why?
|
| Ebstein Anomaly | 1 | 2004 | 106 | 0.010 |
Why?
|
| Water | 1 | 2010 | 1421 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2012 | 2258 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3474 | 0.010 |
Why?
|
| Reimbursement Mechanisms | 1 | 2009 | 670 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4978 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 1321 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2006 | 517 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 3556 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3620 | 0.010 |
Why?
|
| Observation | 1 | 2004 | 310 | 0.010 |
Why?
|
| Mitral Valve Stenosis | 1 | 2004 | 342 | 0.010 |
Why?
|
| Genotype | 1 | 2016 | 13045 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2006 | 829 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3228 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2006 | 1097 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 2005 | 893 | 0.010 |
Why?
|
| Drug Design | 1 | 2006 | 1046 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 1131 | 0.010 |
Why?
|
| Exercise | 1 | 2017 | 5955 | 0.010 |
Why?
|
| Pain Clinics | 1 | 2000 | 50 | 0.010 |
Why?
|
| Medicine | 1 | 2009 | 945 | 0.010 |
Why?
|
| Cholesterol | 1 | 2009 | 2914 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2006 | 2603 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4352 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2023 | 42669 | 0.010 |
Why?
|
| Aorta | 1 | 2008 | 2045 | 0.010 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2004 | 519 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2014 | 5622 | 0.010 |
Why?
|
| Cicatrix | 1 | 2006 | 798 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 2056 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22379 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2015 | 19015 | 0.010 |
Why?
|
| Diet | 1 | 2017 | 8089 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4938 | 0.010 |
Why?
|
| Medicare | 1 | 2017 | 6809 | 0.010 |
Why?
|
| Myocardium | 1 | 2012 | 4788 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 2337 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16726 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11244 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 8054 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 4206 | 0.010 |
Why?
|
| Health Policy | 1 | 2009 | 2698 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8890 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2138 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 6983 | 0.010 |
Why?
|
| Stroke | 1 | 2015 | 9755 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 82029 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 3953 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 13671 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2004 | 26422 | 0.000 |
Why?
|
| Pregnancy | 1 | 2004 | 30256 | 0.000 |
Why?
|
| Heart Failure | 1 | 2006 | 11879 | 0.000 |
Why?
|